Top compounds associated with response to DEFB106B

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	sirolimus:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.028	0.4
mRNA	JQ-1:MK-0752 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.028	0.4
mRNA	BRD-K92856060	CTRPv2	pan-cancer	AAC	-0.029	0.4
mRNA	tigecycline	CTRPv2	pan-cancer	AAC	-0.039	0.4
mRNA	elocalcitol	CTRPv2	pan-cancer	AAC	-0.028	0.4
mRNA	NPC-26	CTRPv2	pan-cancer	AAC	-0.031	0.4
mRNA	RAF265	CTRPv2	pan-cancer	AAC	-0.033	0.4
mRNA	GSK1059615	CTRPv2	pan-cancer	AAC	-0.036	0.4
mRNA	RO4929097	CTRPv2	pan-cancer	AAC	-0.042	0.4
mRNA	doxorubicin:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.026	0.4

Download CSV